NL-OMON50784已完成不适用
The Galvanize Therapeutics Early Stage, Non-Small Cell Lung Cancer, Treat and Resect Study - INCITE ES
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Presence of solitary NSCLC nodule 8th ed. stage IA2, IA3 or IB
- •Nodule measuring > 1 cm and < 4 cm diameter by CT size estimate (e.g. T1b,
- •T1c, T2a), with a minimum 1 cm solid component
- •High pre-procedure probability of malignancy as determined by the
- •investigator
- •Patient has been evaluated by a thoracic surgeon and deemed a candidate for
- •definitive lung tissue resection
- •Patient is, in the opinion of the principal investigator, able to adhere to
- •and undergo bronchoscopy, surgical procedure and post-treatment care
排除标准
- •Additional pulmonary nodules requiring intervention
- •Patient is receiving concurrent cancer treatment (e.g. external beam
- •radiation therapy, brachytherapy, chemotherapy, targeted therapy,
- •immunotherapy, other focal therapy) or has received treatment for the index
- •tumor in the last two years
- •Patient has implanted lung devices or electronic devices
- •Patient has N1 disease
- •Patient is immune compromised or receiving immune modulating medication
- •Recurrent NSCLC within 2 years of initial definitive treatment
- •Previous checkpoint inhibitor treatment for another cancer
研究者
相似试验
尚未招募
不适用
Curative Effect Research in the Late Stage of Granulomatous Mastitis Treated by pricking collaterals and cuppingGranulomatous mastitisITMCTR2200006362Beijing Hospital of Traditional Chinese Medicine
进行中（未招募）
1 期
First line therapy of patients < 60 years suffering from advanced follicular lymphoma who are not in the state of health for the standard immunochemotherapy or for all patients = 60 years. It is a forward-looking comparison of two therapy schemes wherein the patients are assigned to the particular test group according to a special mathematical based principle. In arm 1 only GA 101 and in arm 2 GA 101 and Bendamustin is administered. After the initial therapy only GA 101 is given in both arms.EUCTR2016-000755-27-DEKlinikum der Universität München46
进行中（未招募）
1 期
Radiation-Free Therapy for the Initial treatment of Good prognosis early non-bulky HL, defined by a low Metabolic Tumor Volume and a negative interim PET after 2 chemotherapy cycles- RAFTINGEUCTR2020-002382-33-ITMedical University of Gdansk160
进行中（未招募）
1 期
Radiation-Free Therapy for the Initial treatment of Good prognosis early non-bulky HL, defined by a low Metabolic Tumor Volume and a negative interim PET after 2 chemotherapy cycles- RAFTINGEarly stage classical Hodgkin Lymphoma (cHL) without bulky lesions and constitutional symptomsMedDRA version: 20.1Level: LLTClassification code 10080208Term: Classical Hodgkin lymphomaSystem Organ Class: 100000004864EUCTR2020-002382-33-ESMedical University of Gdansk160
进行中（未招募）
1 期
Radiation-Free Therapy for the Initial treatment of Good prognosis early non-bulky HL, defined by a low Metabolic Tumor Volume and a negative interim PET after 2 chemotherapy cycles- RAFTINGEarly stage classical Hodgkin Lymphoma (cHL) without bulky lesions and constitutional symptomsMedDRA version: 20.1Level: LLTClassification code 10080208Term: Classical Hodgkin lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-002382-33-PLMedical University of Gdansk180